Qiagen N.V. | QIA Annual Report & Investor Relations Data
ISIN
NL0012169213
Ticker
QIA
Sector
Industry
Country
Germany
Year Founded
1984
ISIN
NL0012169213
Ticker
QIA
Sector
Industry
Country
Germany
Year Founded
1984
QIAGEN serves more than 500,000 customers around the globe, all seeking answers from the building blocks of life – DNA, RNA and proteins. We deliver Sample to Insight solutions for molecular testing, propelling our customers from start to finish to unlock new insights. This is how we make improvements in life possible.
Our product portfolio supports our customers across the continuum of molecular testing in molecular diagnostics and life sciences. From the first important step of DNA, RNA and protein extraction from biological samples, to novel testing technologies targeting single or multiple molecular variants, and software to analyze and interpret molecular data to deliver valuable insights. Our automation systems bring together all of these steps in seamless end-to-end workflows.
5,472
Worldwide
| Type | Document | Details | Language | Filing Date | File Number |
|---|
Soon you'll be able to search through every word in Qiagen N.V.'s all filings. Find mentions of specific topics, track strategic initiatives, or analyze historical data.
Access comprehensive European stock market filings data through a single, powerful API.
1,5M+
filings covered
18
European countries
30min
max latency
1 API
for all filings
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 17.04.2023 | S. Rusckowski | Non-Executive member | Other | EUR 0.00 |
| 14.03.2023 | E.R. Mardis | Non-Executive member | Sell | USD 218,422.41 |
| 28.02.2023 | E. Pisa | Non-Executive member | Other | USD 0.00 |
| 21.02.2023 | R. Sackers | Non-Executive member | Other | USD 0.00 |
| 01.12.2022 | R. Sackers | Non-Executive member | Sell | USD 1,500,000.00 |
| 31.10.2022 | M. Colpan | Non-Executive member | Other | USD 0.00 |
| 08.06.2022 | R. Sackers | Non-Executive member | Sell | USD 1,522,706.00 |
| 31.03.2022 | R. Sackers | Non-Executive member | Other | USD 0.00 |
| 15.03.2022 | R. Sackers | Non-Executive member | Other | USD 0.00 |
| 14.03.2022 | E.R. Mardis | Non-Executive member | Sell | USD 228,330.77 |
We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.
NL0012169213
54930036WK3GMCN17Z57
DAX
TecDAX
IATR
Sector
Health Care
Country
Greece
ISIN
GRS147233001
Founded
1984
Athens Medical Group (AMG) was established in 1984. Its goal: to provide high quality, integrated healthcare services, based on a …
BLC
Sector
Health Care
Country
France
ISIN
FR0000035370
Founded
1977
"Taking care of our fellow human beings". The company was created in Nîmes by Guy Bastide, a pharmacist by training. …
BCART
Sector
Health Care
Country
Belgium
ISIN
BE0974281132
Founded
2007
Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide …
BRA
Sector
Health Care
Country
Poland
ISIN
PLBRSTR00014
Founded
2008
BRASTER S.A. is an innovative technological company operating in the field of telemedicine. The core business of the company is …
CARA
Sector
Health Care
Country
Norway
ISIN
NO0010123060
Founded
1997
Carasent ASA was founded in 1997. In May 2018, the Swedish company Evimeria EMR AB, a provider of cloud-based medical …
CBAV
Sector
Health Care
Country
Spain
ISIN
ES0119037010
Founded
1992
Clínica Baviera is a European reference in the diagnosis, treatment and follow-up of all types of ophthalmological disorders. Our state-of-the-art …